Estimation of maximum tolerated dose and minimum efficient dose of BP-C1 in the treatment of stage IV breast cancer patients: A phase I response surface pathway designed study.
Stig Einride Larsen
No relevant relationships to disclose
Sagita Dewi
No relevant relationships to disclose
Vichien Srimuninnimit
No relevant relationships to disclose
Yen-Shen Lu
No relevant relationships to disclose
Tjakra Manuaba
No relevant relationships to disclose
Steen Lindkaer Jensen
No relevant relationships to disclose